Oral Iron
Sponsors
J. Uriach and Company, Sanofi, Watson Pharmaceuticals, AMAG Pharmaceuticals, Inc., Kyntra Bio
Conditions
AnemiaAnemia of Chronic Kidney DiseaseAnemia, Iron DeficiencyAnemia, Iron-DeficiencyCeliac DiseaseColorectal NeoplasmDialysisEPP
Phase 1
Phase 2
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
CompletedNCT00223977
Start: 2003-12-31End: 2008-02-29Updated: 2013-07-08
Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment
CompletedNCT01414075
Start: 2011-07-21End: 2013-01-10Updated: 2021-10-01
Phase 3
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
TerminatedNCT01155375
Start: 2011-10-17End: 2014-06-24Updated: 2022-04-04
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
TerminatedNCT01155388
Start: 2011-10-17End: 2014-06-24Updated: 2022-04-28
Intravenous High Dose Iron in Blood Donors
CompletedNCT01787526
Start: 2014-06-30End: 2016-08-31Updated: 2016-10-06
A Randomized Trial of Oral Iron Therapy in Fibromyalgia
CompletedNCT01820052
Start: 2013-04-30End: 2015-12-31Updated: 2018-04-20
Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty
CompletedNCT01857011
Start: 2014-04-30End: 2016-06-30Updated: 2017-01-24
Intravenous Versus Oral Iron Therapy in Hemodialysis Patients
NCT04464850
Start: 2020-07-29End: 2022-07-31Target: 124Updated: 2020-08-11
Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis
NCT05225545
Start: 2019-11-04End: 2024-05-04Target: 30Updated: 2024-01-31
Phase 4
Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.
NCT00199277
Target: 150Updated: 2005-09-20
Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
TerminatedNCT00223938
Start: 2003-12-30End: 2007-04-27Updated: 2021-06-24
Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)
Not yet recruitingNCT05114278
Start: 2022-02-15End: 2026-04-15Target: 204Updated: 2022-01-19
Efficacy and Safety of Lactoferrin in Heart Failure Patients
Not yet recruitingNCT06427200
Start: 2024-07-31End: 2027-07-31Target: 114Updated: 2024-05-24
Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients
CompletedNCT06556134
Start: 2021-07-01End: 2024-01-10Updated: 2024-08-15